Expanding the drug discovery space with predicted metabolite–target interactions
Using computational approaches, Nuzzo et al. identify 983 potential metabolite–human target interactions from the Inflammatory Bowel Disease (IBD) cohort dataset of the Human Microbiome Project 2 (HMP2) and public databases. These predicted interactions can further the understanding of host–microbio...
Enregistré dans:
Auteurs principaux: | Andrea Nuzzo, Somdutta Saha, Ellen Berg, Channa Jayawickreme, Joel Tocker, James R. Brown |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/75f87b3c80b74ee3b132d5f3e4bd2ef1 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Predicting the Reliability of Drug-target Interaction Predictions with Maximum Coverage of Target Space
par: Antonio Peón, et autres
Publié: (2017) -
Editorial: Protein–Protein Interactions: Drug Discovery for the Future
par: Simona Rapposelli, et autres
Publié: (2021) -
Can the HIV-1 splicing machinery be targeted for drug discovery?
par: Dlamini Z, et autres
Publié: (2017) - Drug Discovery
-
Expanding the interaction equivalency theorem
par: Brenda Cecilia Padilla Rodriguez, et autres
Publié: (2015)